Turkey is getting its first locally produced mAb via an Iranian biosimilars marker and the $100 million plant it built there. CinnaGen Pharmaceuticals has opened the plant in Çerkezköy, in northwestern Turkey's Tekirda?, the Daily Sabah reports. Details were few but the CinnaGen CEO ?laç Ferhat Far?i told the publication that American scientists were among its employees.